Solco Healthcare LLC
NDC labeler code: 43547
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- Potassium chlorideKlor-Con, Klor-Con M, Pokonza · 5 products
- ClonidineClonidine Transdermal System, Clonidine Transdermal System Usp, 0.1 Mg/Day, Clonidine Transdermal System Usp, 0.2 Mg/Day · 4 products
- Lisinopril and hydrochlorothiazideZestoretic · 3 products
- PioglitazoneActos · 3 products
- Telmisartan and hydrochlorothiazideMicardis Hct · 3 products
- ClonazepamKlonopin · 3 products
- Candesartan cilexetil and hydrochlorothiazideAtacand Hct · 3 products
- HydrocortisoneSolu-Cortef, Proctozone-Hc, Alkindi Sprinkle · 3 products
- Fosinopril sodium3 products
- BumetanideBumex, Enbumyst · 3 products
- FurosemideLasix, Furoscix, Lasix Onyu · 3 products
- MethocarbamolRobaxin, Atmeksi, Tanlor · 2 products
- EntecavirBaraclude · 2 products
- ParoxetinePaxil, Paxil CR, Brisdelle · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| February 25, 2026 | ANDA220329 | Hydrocortisone HYDROCORTISONE | Appco |
| September 18, 2024 | ANDA212931 | Bumetanide BUMETANIDE | Appco |
| June 11, 2019 | ANDA209026 | Potassium chloride POTASSIUM CHLORIDE | Prinston |
| April 30, 2019 | ANDA209922 | Potassium chloride POTASSIUM CHLORIDE | Prinston |
| April 17, 2018 | ANDA207806 | Pioglitazone PIOGLITAZONE HYDROCHLORIDE | Prinston |
| April 11, 2018 | ANDA207455 | Candesartan cilexetil and hydrochlorothiazide CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | Prinston |
| November 20, 2017 | ANDA209757 | Clonidine CLONIDINE HYDROCHLORIDE | Xiamen LP Pharm Co |
| November 6, 2017 | ANDA209028 | Telmisartan and hydrochlorothiazide TELMISARTAN AND HYDROCHLOROTHIAZIDE | Prinston |
| October 10, 2017 | ANDA208782 | Entecavir ENTECAVIR | Prinston |
| August 18, 2017 | ANDA207188 | Paroxetine PAROXETINE MESYLATE | Prinston |
| August 29, 2016 | ANDA205670 | Fosinopril sodium FOSINOPRIL SODIUM | Prinston |
| March 9, 2007 | ANDA077901 | Clonidine CLONIDINE HYDROCHLORIDE | Prinston |
| June 28, 2006 | ANDA077856 | Clonazepam CLONAZEPAM | Prinston |
| March 26, 2004 | ANDA076796 | Furosemide FUROSEMIDE | Prinston |
| July 1, 2002 | ANDA076230 | Lisinopril and hydrochlorothiazide LISINOPRIL AND HYDROCHLOROTHIAZIDE | Prinston Inc |
| October 29, 1979 | ANDA086988 | Methocarbamol METHOCARBAMOL | Prinston Inc |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2022
-
January 26, 2022 · Class II · Terminated · D-0176-2024 · Donepezil hydrochloride
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Donepezil HCl Tablets, 10 mg, 90 Tablets, Rx only, Distributed by: Solco Healthcare U.S. LLC, Hurracao, Puerto Rico 00791. NDC: 43547-276-09
-
January 26, 2022 · Class II · Terminated · D-0177-2024 · Donepezil hydrochloride
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Donepezil HCl Tablets, 5 mg, 90 Tablets, Rx only, Distributed by: Solco Healthcare U.S. LLC, Hurracao, Puerto Rico 00791. NDC: 43547-275-09
2019
-
January 18, 2019 · Class II · Completed · D-0409-2019 · Irbesartan
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Irbesartan Tablets 300 mg 90 count Rx only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Xunqiao, Linhai, Zhejiang 317024 China Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512 NDC 43547-376-09
-
January 18, 2019 · Class II · Completed · D-0413-2019 · Irbesartan and hydrochlorothiazide
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Irbesartan and Hydrochlorothiazide Tablets, USP 150/12.5 mg Rx 30 Tablets Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cr
-
January 18, 2019 · Class II · Completed · D-0410-2019 · Irbesartan and hydrochlorothiazide
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Irbesartan and HydrochlorothiazideTablets, USP 150/12.5 mg Rx Only 90 count Manufactured by: Zhejiang Huahai Pharmaceutical Co., Xunqiao, Linhai, Zhejiang 317024 China Distributed by: Solco Healthcare US, LLC Cranbury, N
-
January 18, 2019 · Class II · Completed · D-0411-2019 · Irbesartan and hydrochlorothiazide
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ
-
January 18, 2019 · Class II · Completed · D-0412-2019 · Irbesartan and hydrochlorothiazide
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China Distributed by: Solco Healthcare US, LLC Cranbury, NJ
2018
-
July 13, 2018 · Class II · Ongoing · D-0971-2018 · Valsartan
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Solco Healthcare US Valsartan, USP, 320 MG Tablets, 90-count bottle,Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xynqiao, Linhai, Zhejiang 317024, China Distributed by: Solco Healthcare US, LLC Cranb
-
July 13, 2018 · Class II · Ongoing · D-0969-2018 · Valsartan
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Solco Healthcare US Valsartan, USP, 80 MG Tablets, 90-count bottle, Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xynqiao, Linhai, Zhejiang 317024, China Distributed by: Solco Healthcare US, LLC Cranb
-
July 13, 2018 · Class II · Ongoing · D-0970-2018 · Valsartan
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Solco Healthcare US Valsartan, USP, 160 MG Tablets, 90-count bottles, Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xynqiao, Linhai, Zhejiang 317024, China Distributed by: Solco Healthcare US, LLC Cra
Show the 8 older recalls
2018
-
July 13, 2018 · Class II · Ongoing · D-0975-2018 · Valsartan and hydrochlorothiazide
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Solco Healthcare US Valsartan and Hydrochlorothiazide, USP, 320 MG/12.5 MG Tablets, 90-count bottle, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xynqiao, Linhai, Zhejiang 317024, China Distributed
-
July 13, 2018 · Class II · Ongoing · D-0976-2018 · Valsartan and hydrochlorothiazide
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Solco Healthcare US Valsartan and Hydrochlorothiazide, USP, 320 MG/25 MG Tablets, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xynqiao, Linhai, Zhejiang 317024, China Distributed b
-
July 13, 2018 · Class II · Ongoing · D-0968-2018 · Valsartan
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Solco Healthcare US Valsartan, USP, 40 MG Tablets, 30- count bottle, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xynqiao, Linhai, Zhejiang 317024, China Distributed by: Solco Healthcare US, LLC Cra
-
July 13, 2018 · Class II · Ongoing · D-0973-2018 · Valsartan and hydrochlorothiazide
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Solco Healthcare US Valsartan and Hydrochlorothiazide, USP, 160 MG/12.5 MG Tablets, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xynqiao, Linhai, Zhejiang 317024, China Distributed
-
July 13, 2018 · Class II · Ongoing · D-0974-2018 · Valsartan and hydrochlorothiazide
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Solco Healthcare US Valsartan and Hydrochlorothiazide, USP, 160 MG/25 MG Tablets, 90-count bottle, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xynqiao, Linhai, Zhejiang 317024, China Distributed by
-
July 13, 2018 · Class II · Ongoing · D-0972-2018 · Valsartan and hydrochlorothiazide
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Solco Healthcare US Valsartan and Hydrochlorothiazide, USP, 80 MG/12.5 MG Tablets, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xynqiao, Linhai, Zhejiang 317024, China Distributed
2017
-
November 29, 2017 · Class II · Terminated · D-0209-2018 · Valsartan
Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.
Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare US, LLC, Cranbury, NJ 08512,
2016
-
May 30, 2016 · Class III · Terminated · D-1049-2016 · Irbesartan and hydrochlorothiazide
Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect lot number, 327B160012, appears on the case label, the correct lot number, 327B16002 appears on the immediate container.
Irbesartan and Hydrochlorothiazide Tablets, USP, 300/12.5 mg, Rx only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare U.S., LLC, Cranbu
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026